Paragonix Technologies’ $24 Million Series B Investment

Sheppard Mullin advised Signet Healthcare Partners on the deal.Paragonix Technologies, Inc., a leading organ transplant company, announced that it has secured $24 million in Series B…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here